K Tokunaga Selected Research

K Tokunaga Research Topics

Disease

7	Narcolepsy 12/2015 - 11/2000
5	Infections 12/2015 - 01/2000
5	Rheumatoid Arthritis 03/2007 - 04/2000
5	Malaria 03/2007 - 01/2001
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2002 - 12/2000
4	Aneurysm (Aneurysms) 02/2005 - 01/2000
4	Hypertension (High Blood Pressure) 12/2001 - 05/2000
3	Neoplasms (Cancer) 01/2007 - 08/2000
3	Type 2 Diabetes Mellitus (MODY) 07/2005 - 05/2000
2	Tuberculosis (Tuberculoses) 01/2017 - 10/2016
2	Alveolar Bone Loss 12/2011 - 06/2008
2	Periodontitis 12/2011 - 06/2008
2	Disease Susceptibility (Diathesis) 01/2009 - 02/2000
2	Bone Resorption 06/2008 - 01/2001
2	Cerebral Malaria 05/2008 - 03/2007
2	Leukemia 08/2007 - 04/2001
2	Hematologic Neoplasms (Hematological Malignancy) 08/2006 - 02/2004
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2004 - 08/2000
2	Intracranial Aneurysm (Cerebral Aneurysm) 07/2003 - 08/2000
2	Rheumatic Diseases (Rheumatism) 03/2003 - 06/2000
2	Insulin Resistance 12/2001 - 12/2001
2	Necrosis 07/2001 - 02/2001
2	Schizophrenia (Dementia Praecox) 12/2000 - 07/2000
2	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 09/2000 - 01/2000
1	Chemical and Drug Induced Liver Injury 10/2016
1	Cataplexy 12/2015
1	Chronic Hepatitis B 12/2015
1	Hepatitis B 12/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2009
1	Vertebrobasilar Insufficiency 08/2009
1	Bowen's Disease (Disease, Bowen) 06/2009
1	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2007
1	Asthma (Bronchial Asthma) 05/2006
1	Microscopic Polyangiitis 01/2006
1	Vasculitis (Vasculitides) 01/2006
1	Polyploidy 01/2004
1	Rib Fractures (Rib Fracture) 09/2003

Drug/Important Bio-Agent (IBA)

14	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 04/2000
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008 - 04/2000
7	Type II Tumor Necrosis Factor ReceptorsIBA 10/2001 - 04/2000
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2009 - 02/2000
4	HLA-B Antigens (HLA-B)IBA 03/2007 - 02/2000
4	Proteins (Proteins, Gene)FDA Link 11/2004 - 01/2000
3	Messenger RNA (mRNA)IBA 09/2003 - 12/2000
3	Triglycerides (Triacylglycerol)IBA 12/2001 - 05/2000
3	Insulin (Novolin)FDA Link 12/2001 - 05/2000
3	Glucose (Dextrose)FDA LinkGeneric 12/2001 - 05/2000
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2001 - 04/2000
3	SolutionsIBA 09/2000 - 05/2000
2	AntigensIBA 12/2015 - 02/2001
2	Peptides (Polypeptides)IBA 12/2015 - 03/2007
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2015 - 05/2008
2	Parathyroid Hormone (Parathormone)IBA 12/2011 - 01/2001
2	Nylons (Nylon)IBA 12/2011 - 06/2008
2	CytokinesIBA 05/2008 - 12/2000
2	HLA-A Antigens (HLA-A)IBA 08/2007 - 02/2000
2	AutoantibodiesIBA 03/2007 - 10/2002
2	AntibodiesIBA 03/2007 - 02/2001
2	DNA (Deoxyribonucleic Acid)IBA 05/2006 - 06/2000
2	NucleotidesIBA 10/2003 - 12/2000
2	SiliconesIBA 07/2003 - 03/2002
2	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 12/2000 - 07/2000
2	Fibrinogen (Factor I)FDA Link 11/2000 - 05/2000
2	HDL CholesterolIBA 11/2000 - 05/2000
2	PolymersIBA 09/2000 - 08/2000
2	acetylcelluloseIBA 09/2000 - 08/2000
1	Virulence Factors (Pathogenicity Factors)IBA 01/2017
1	Antitubercular AgentsIBA 10/2016
1	HLA-DP Antigens (HLA-DP)IBA 12/2015
1	HLA-DPB1 antigen (HLA DPB1)IBA 12/2015
1	HLA-DQB1 antigen (HLA DQB1)IBA 12/2015
1	gossypol acetic acidIBA 12/2009
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2009
1	Simvastatin (Zocor)FDA LinkGeneric 06/2008
1	cyclic citrullinated peptideIBA 03/2007
1	Anti-Citrullinated Protein AntibodiesIBA 03/2007
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 01/2007
1	A-Form DNA (A-DNA)IBA 01/2007
1	fms-Like Tyrosine Kinase 3IBA 08/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2006
1	Metalloproteases (Metalloproteinases)IBA 05/2006
1	DisintegrinsIBA 05/2006
1	Peroxidase (Myeloperoxidase)IBA 01/2006
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2006
1	Adiponectin ReceptorsIBA 07/2005
1	FollistatinIBA 11/2004
1	Interleukin-13IBA 10/2003
1	Interleukin-3 (Interleukin 3)IBA 10/2003
1	Interleukin-4 (Interleukin 4)IBA 10/2003
1	Natural Killer Cell ReceptorsIBA 03/2003
1	HLA-A*33 antigenIBA 12/2002
1	Fc gamma receptor IIAIBA 12/2002

Therapy/Procedure

2	Ligation 12/2011 - 06/2008
2	Topical Administration 12/2011 - 06/2008
2	Stents 08/2009 - 02/2005
2	Drug Therapy (Chemotherapy) 10/2001 - 04/2001
1	Tissue Transplantation 01/2009
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2009
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2004
1	Lasers (Laser) 01/2004